Pharmacyclics, an AbbVie subsidiary, is focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune-mediated diseases. The company’s mission is to improve the quality of life and resolve serious unmet medical needs. Pharmacyclics markets IMBRUVICA and has two product candidates in clinical development. Learn more at Pharmacyclics.com.
At Janssen Biotech, Inc. we have an urgent commitment to make a difference for cancer patients and those living with autoimmune diseases. Comprised of Janssen Oncology and Janssen Immunology, we deliver transformational biologic medicines to market, and have built a rich legacy of innovative firsts. For more information, visit www.janssen.com.
999 East Arques Ave
Sunnyvale, California 94085